TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11867107

Group type: EXPERIMENTAL
Intervention: Intracoronary beta radiation with a phosphorus-32 source (n=166)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo (n=166)
Number of subjects: 332
Study: 10594527

Group type: EXPERIMENTAL
Intervention: 0.3 mg/day conjugated equine oestrogens (CEE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.6 mg/day conjugated equine oestrogens (CEE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1.25 mg/day conjugated equine oestrogens (CEE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All doses of CEE
Number of subjects: 36
Study: 7773275

Group type: EXPERIMENTAL
Intervention: Isokinetic testing in the coronal plane at 90 degrees/sec
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isokinetic testing in the scapular plane at 90 degrees/sec
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isokinetic testing in the coronal plane at 210 degrees/sec
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isokinetic testing in the scapular plane at 210 degrees/sec
Number of subjects: 20
Study: 2085344

Group type: EXPERIMENTAL
Intervention: Acamprosate (CA), 1.3 g/day
Number of subjects: 569

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Acamprosate (CA)
Number of subjects: 569
Study: 28278602

Group type: EXPERIMENTAL
Intervention: CBT-only treatment (ACTION Treatment; Stark et al., 2006)
Number of subjects: 40
Study: 28666535

Group type: EXPERIMENTAL
Intervention: Childcare intervention alone (CC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Childcare intervention with parental involvement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical curriculum comparison group
Number of subjects: 0
Study: 24691494

Group type: EXPERIMENTAL
Intervention: Adherence Therapy (AT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 70
Study: 23674614

Group type: EXPERIMENTAL
Intervention: 3 T magnetic field exposure for 20 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not exposed to 3 T magnetic field)
Number of subjects: 60
Study: 22030047

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) followed by misoprostol (100 μg or 50 μg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Misoprostol (100 μg or 50 μg) alone
Number of subjects: 40
Study: 19034052

Group type: EXPERIMENTAL
Intervention: E-EPA omega-3 fatty acid supplementation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 17453591

Group type: EXPERIMENTAL
Intervention: Structured interrupted therapy (SIT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuous therapy (CT)
Number of subjects: 40
Study: 15212115

Group type: EXPERIMENTAL
Intervention: TMS-induced cortical silent period (CSP) in SCA2 patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TMS-induced cortical silent period (CSP) in IDCA patients
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 12377961

Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma cell lysates (VMCL)
Number of subjects: 700

Group type: COMPARATOR
Intervention: No immunotherapy (control)
Number of subjects: 700
Study: 9840563

Group type: EXPERIMENTAL
Intervention: Daily conjugated equine estrogens
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus cyclical medroxyprogesterone acetate
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus daily medroxyprogesterone acetate
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens plus cyclical micronized progesterone
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Progestin-containing regimens
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate and micronized progesterone regimens
Number of subjects: 875

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 875

Group type: EXPERIMENTAL
Intervention: Anxiety, cognitive, and affective symptoms
Number of subjects: 875
Study: 7856287

Group type: EXPERIMENTAL
Intervention: Mumps vaccine, strain Sofia 6
Number of subjects: 0
Study: 2570656

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 525

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study: 326281

Group type: EXPERIMENTAL
Intervention: Diazepam 0.2 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Diazepam 0.3 mg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 30761665

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Parent-focused treatment (PFT)
Number of subjects: 106
Study: 28380223

Group type: EXPERIMENTAL
Intervention: Self-evaluation by pre-service teachers
Number of subjects: 21

Group type: COMPARATOR
Intervention: Evaluation by school mentors
Number of subjects: 21
Study: 26394259

Group type: EXPERIMENTAL
Intervention: High whey yogurt (HW) C:W = 1.5:1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: +IN-βG yogurt (1.9 g of inulin and 0.5 g of β-glucan)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control yogurt (C:W = 2.8:1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fibre-enriched formulations (2.4 g of inulin and 0.5 g of β-glucan)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Yogurt with 0.5 g of β-glucan
Number of subjects: 20
Study: 23480498

Group type: EXPERIMENTAL
Intervention: Breast Cancer Patient Pathway program (Internet-based patient educational program)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 90
Study: 21241922

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg, 3 times daily for 7 days (2 days before and 4 days after surgery)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo, 3 times daily for 7 days (2 days before and 4 days after surgery)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 19225118

Group type: EXPERIMENTAL
Intervention: 18:2 (safflower oil)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 18:1 (canola oil)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no fat infusion)
Number of subjects: 15
Study: 16925697

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: ocular blood flow pneumatonometer (OBFT)
Number of subjects: 104
Study: 14682220

Group type: EXPERIMENTAL
Intervention: Monophasic shock cardioversion (CV)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Biphasic shock cardioversion (CV)
Number of subjects: 63
Study: 10857213

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 2 mg daily in combination with ethinylestradiol (EE2) 35 mg or 50 mg
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA) 2 mg daily
Number of subjects: 57
Study: 9088884

Group type: EXPERIMENTAL
Intervention: Oral SRI drugs (standardized treatment for 10 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No specific intervention mentioned for the control group (absence of OCPD)
Number of subjects: 30
Study: 8256902

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (2.5 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (7.5 mg cumulative dose)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (15.0 mg cumulative dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: MDI albuterol (100 puffs, 9 mg)
Number of subjects: 10
Study: 3899418

Group type: EXPERIMENTAL
Intervention: Indapamide (2.5 mg/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 30772533

Group type: EXPERIMENTAL
Intervention: Triggers for atrial fibrillation (AF)
Number of subjects: 1295
Study: 29587770

Group type: EXPERIMENTAL
Intervention: Powdered Nigella sativa
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27094555

Group type: EXPERIMENTAL
Intervention: Coaching
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coupons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fruits and Vegetables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low Fat
Number of subjects: 0
Study: 24315979

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 80
Study: 22544004

Group type: EXPERIMENTAL
Intervention: Open-label olanzapine treatment (2.5 or 5 mg/d, increased up to 20 mg/d in study 1 or 15 mg/d in study 2)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Open-label olanzapine treatment after placebo during the acute phase
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Open-label olanzapine treatment after olanzapine during the acute phase
Number of subjects: 472
Study: 20416995

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 18922335

Group type: EXPERIMENTAL
Intervention: Pillar palate implants
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham placebo
Number of subjects: 100
Study: 15014218

Group type: EXPERIMENTAL
Intervention: LocaLisa non‐fluoroscopic catheter navigation system
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fluoroscopic guidance alone (Control)
Number of subjects: 21
Study: 12458116

Group type: EXPERIMENTAL
Intervention: Combined antiemetic strategy including nursing intervention program (increased access to support and increased information) and antiemetics based on high‐dose metoclopramide and dexamethasone
Number of subjects: 162

Group type: COMPARATOR
Intervention: Ondansetron plus dexamethasone
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard antiemetic treatment during the 1980s
Number of subjects: 162
Study: 9654537

Group type: EXPERIMENTAL
Intervention: Walking during active labor
Number of subjects: 536

Group type: COMPARATOR
Intervention: Usual care (no walking)
Number of subjects: 536
Study: 8081005

Group type: EXPERIMENTAL
Intervention: CY-TBI (60 mg/kg cyclophosphamide on each of 2 successive days followed by 6 fractions of total body irradiation each of 2.0 Gy)
Number of subjects: 142

Group type: COMPARATOR
Intervention: BU-CY (16 mg/kg busulfan over 4 days followed by 60 mg/kg cyclophosphamide on each of 2 successive days)
Number of subjects: 142
Study: 2526824

Group type: EXPERIMENTAL
Intervention: Acitretin 10 mg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Acitretin 25 mg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Acitretin 50 mg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Acitretin 75 mg/day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 176881

Group type: EXPERIMENTAL
Intervention: Xylitol infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose infusion
Number of subjects: 0
Study: 28407722

Group type: EXPERIMENTAL
Intervention: Induced hypothermia at 33°C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group at 36°C
Number of subjects: 0
Study: 26716587

Group type: EXPERIMENTAL
Intervention: Transulnar access (TUA)
Number of subjects: 2532

Group type: COMPARATOR
Intervention: Transradial access (TRA)
Number of subjects: 2532
Study: 24684808

Group type: EXPERIMENTAL
Intervention: Task-oriented robot-assisted arm-hand training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Task-oriented non-robotic arm-hand training (Control)
Number of subjects: 22
Study: 22674157

Group type: EXPERIMENTAL
Intervention: Lumbar epidural morphine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Thoracic epidural morphine
Number of subjects: 55
Study: 19744087

Group type: EXPERIMENTAL
Intervention: Endurance athletes
Number of subjects: 96

Group type: COMPARATOR
Intervention: Hypertensive patients
Number of subjects: 96

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 96
Study: 17700400

Group type: EXPERIMENTAL
Intervention: RAA pacing during DDD
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: IAS pacing during DDD
Number of subjects: 42

Group type: COMPARATOR
Intervention: IAS pacing
Number of subjects: 42

Group type: COMPARATOR
Intervention: RAA pacing
Number of subjects: 42
Study: 16282841

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12139223

Group type: EXPERIMENTAL
Intervention: Halofantrine (500 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Co-artemether (80/480 mg)
Number of subjects: 13
Study: 10334254

Group type: COMPARATOR
Intervention: Continuous running suture (CRS) technique
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Continuous double-loop closure (CDLC) technique
Number of subjects: 390
Study: 8588061

Group type: EXPERIMENTAL
Intervention: 75-100 mg/day amitriptyline (n=16)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 200 mg/day amineptine (n=10)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Baseline rCBF values of depressed patients
Number of subjects: 26

Group type: COMPARATOR
Intervention: Chronic treatment with classic tricyclic antidepressants
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dopaminergic drugs
Number of subjects: 26
Study: 1760779

Group type: EXPERIMENTAL
Intervention: Brushing with denture paste (Dentu-Creme)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Soaking in Efferdent
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Brushing followed by soaking in Efferdent
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 18
Study: 6817270

Group type: EXPERIMENTAL
Intervention: 1% glycopyrrolate roll-on lotion and cream
Number of subjects: 22

Group type: COMPARATOR
Intervention: Topical scopolamine (solution and cream)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Glycopyrrolate (roll-on lotion, solution, and cream)
Number of subjects: 22
Study: 31468214

Group type: EXPERIMENTAL
Intervention: Fluid-restrictive vasopressor-dominated hemodynamic support (FRV) with norepinephrine concentration of 0.065±0.020 μg/kg/min
Number of subjects: 44

Group type: COMPARATOR
Intervention: Liberal fluid administration (LFA) with fluid administration of 5.1±2.2 ml/kg/h
Number of subjects: 44
Study: 31617141

Group type: EXPERIMENTAL
Intervention: Stiripentol as adjunctive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stiripentol with clobazam and valproate
Number of subjects: 0
Study: 28831954

Group type: EXPERIMENTAL
Intervention: Diet D:E‐1·09
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Diet D:E‐2·05
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diet D:E‐0·68
Number of subjects: 90
Study: 26391775

Group type: EXPERIMENTAL
Intervention: Dignity Therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Supportive Attention
Number of subjects: 90
Study: 23235272

Group type: EXPERIMENTAL
Intervention: Prefrontal transcranial direct current stimulation (tDCS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study: 22244642

Group type: EXPERIMENTAL
Intervention: ProTaper rotary instruments
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Self-adjusting file (SAF) system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (ProTaper rotary instruments)
Number of subjects: 50
Study: 20124283

Group type: EXPERIMENTAL
Intervention: Preoperative multimedia information (short film depicting in-hospital journey)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no multimedia information)
Number of subjects: 110
Study: 16533861

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recovered depressed subjects
Number of subjects: 0
Study: 16313817

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel plus carboplatin
Number of subjects: 125

Group type: COMPARATOR
Intervention: Three weeks paclitaxel plus carboplatin
Number of subjects: 125
Study: 12399344

Group type: EXPERIMENTAL
Intervention: Home visits by community nurse at one and four weeks after discharge and preventive general practitioner care
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Home visits by community nurse
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Knowledge and satisfaction measures
Number of subjects: 177

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 177

Group type: COMPARATOR
Intervention: General practitioner involvement
Number of subjects: 177
Study: 10660174

Group type: EXPERIMENTAL
Intervention: Toronto SPV stentless bioprosthesis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carpentier Edwards SAV (CE) bioprosthesis
Number of subjects: 40
Study: 7775623

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen (Estraderm‐TTS 100)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oral estrogen (Premarin, 1.25 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both oral and transdermal estrogen
Number of subjects: 9
Study: 2310655

Group type: EXPERIMENTAL
Intervention: 3 g day-1 acetylsalicylic acid
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 3 g day-1 paracetamol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1.5 g day-1 acetylsalicylic acid and 1.5 g day-1 paracetamol (combination)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 1.5 g day-1 acetylsalicylic acid (separated by washout phases)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: All four drug schedules
Number of subjects: 11
Study: 6184562

Group type: EXPERIMENTAL
Intervention: VER (80 mg t.i.d.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NIF (10 mg t.i.d.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: VER (160 mg t.i.d.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: VER (80 mg t.i.d.) and NIF (10 mg t.i.d.)
Number of subjects: 12
Study: 31541880

Group type: EXPERIMENTAL
Intervention: Manipulated distributions of speed and direction tuning widths in convolutional networks for visual odometry and gesture recognition tasks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random linear mixtures of the responses in convolutional networks.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Responses randomized while maintaining representational dissimilarity.
Number of subjects: 0
Study: 30691510

Group type: EXPERIMENTAL
Intervention: Hyperoxemia or hypoxemia exposure during the first 37 hours after ROSC
Number of subjects: 869

Group type: EXPERIMENTAL
Intervention: Peak serum Tau levels at 48 or 72 hours after ROSC
Number of subjects: 869
Study: 28840263

Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open-loop insulin delivery
Number of subjects: 20
Study: 25901546

Group type: EXPERIMENTAL
Intervention: Aerosolized albuterol
Number of subjects: 25
Study: 23836575

Group type: EXPERIMENTAL
Intervention: Waterless hand sanitizer intervention
Number of subjects: 8733

Group type: EXPERIMENTAL
Intervention: Handwashing with soap intervention
Number of subjects: 8733

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 8733
Study: 17529914

Group type: EXPERIMENTAL
Intervention: Electronic Dental Anaesthesia (EDA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (regional anaesthesia)
Number of subjects: 60
Study: 15296021

Group type: EXPERIMENTAL
Intervention: Inpatient counseling with postdischarge telephone contacts at 7, 21 and 42 days after discharge
Number of subjects: 106

Group type: COMPARATOR
Intervention: Public health nurse‐mediated behaviorally oriented inpatient counseling (control group)
Number of subjects: 106
Study: 11014673

Group type: EXPERIMENTAL
Intervention: Myopic group (children with myopia)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Nonmyopic group (children without myopia)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Nearwork scores from diaries
Number of subjects: 168
Study: 9110517

Group type: EXPERIMENTAL
Intervention: Integrated mental health and substance abuse treatment program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard psychiatric hospital treatment
Number of subjects: 0
Study: 8408725

Group type: EXPERIMENTAL
Intervention: 0.01% triclosan mouthrinse
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.05% triclosan mouthrinse
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.1% triclosan mouthrinse
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.2% triclosan mouthrinse
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (minus-active control)
Number of subjects: 30
Study: 3317338

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study: 30430201

Group type: EXPERIMENTAL
Intervention: Water-running, moderate-intensity exercise (60-70%), two times/week
Number of subjects: 42

Group type: COMPARATOR
Intervention: No additional treatment other than the prescribed medication (Control)
Number of subjects: 42
Study: 28399981

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors plus insulin
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo plus insulin
Number of subjects: 178
Study: 26370528

Group type: EXPERIMENTAL
Intervention: Protective group (Group P) - tidal volume of 6 mL/kg, FiO2 of 80%, PEEP of 5 cm H2O
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional group (Group C) - tidal volume of 8 mL/kg, FiO2 of 100%
Number of subjects: 60
Study: 23381490

Group type: EXPERIMENTAL
Intervention: Neck Disability Index (NDI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SF-12 Physical Component Scale (SF-12 PCS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: EuroQol-5D (EQ-5D)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Zung Self-Rating Depression Scale
Number of subjects: 50
Study: 20824894

Group type: EXPERIMENTAL
Intervention: Saffron 60 mg/day for 26 weeks
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo for 26 weeks
Number of subjects: 260
Study: 19154568

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 111
Study: 16648499

Group type: EXPERIMENTAL
Intervention: 78 Gy radiotherapy
Number of subjects: 669

Group type: COMPARATOR
Intervention: 68 Gy radiotherapy
Number of subjects: 669